These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19442516)

  • 1. Non-surgical treatment of localised prostate cancer.
    Moule RN; Hoskin PJ
    Surg Oncol; 2009 Sep; 18(3):255-67. PubMed ID: 19442516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer.
    Jereczek-Fossa BA; Orecchia R
    Radiother Oncol; 2007 Aug; 84(2):197-215. PubMed ID: 17532494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
    Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
    Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes in younger men following permanent prostate brachytherapy.
    Shapiro EY; Rais-Bahrami S; Morgenstern C; Napolitano B; Richstone L; Potters L
    J Urol; 2009 Apr; 181(4):1665-71; discussion 1671. PubMed ID: 19233394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic pelvic lymph-node dissection in prostate cancer before external beam radiotherapy: Risk factors of nodal involvement and relapse following intended curative treatment.
    Bjerggaard Jensen J; Johansen JK; Graversen PH
    Scand J Urol Nephrol; 2009; 43(1):19-24. PubMed ID: 18752151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
    Satoh T; Ishiyama H; Matsumoto K; Tsumura H; Kitano M; Hayakawa K; Ebara S; Nasu Y; Kumon H; Kanazawa S; Miki K; Egawa S; Aoki M; Toya K; Yorozu A; Nagata H; Saito S; Baba S
    BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
    Tanaka N; Fujimoto K; Hirao Y; Asakawa I; Hasegawa M; Konishi N
    Urology; 2009 Aug; 74(2):407-11. PubMed ID: 19376570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.
    Pe ML; Trabulsi EJ; Kedika R; Pequignot E; Dicker AP; Gomella LG; Valicenti RK
    Urology; 2009 Jun; 73(6):1328-34. PubMed ID: 19376564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rate brachytherapy for prostate cancer.
    Hoskin P
    Cancer Radiother; 2008 Nov; 12(6-7):512-4. PubMed ID: 18755623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low and intermediate risk prostate cancer-- role of hormonal therapy with external beam radiation therapy.
    Martin J; Bristow R; Warde P
    Can J Urol; 2006 Apr; 13 Suppl 2():63-7. PubMed ID: 16672132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological modifications observed in prostate after preserving treatments for prostate cancer and their impact on Gleason score interpretation].
    Molinié V; Mahjoub WK; Balaton A
    Ann Pathol; 2008 Oct; 28(5):363-73. PubMed ID: 19068391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer.
    Hurwitz MD
    Nat Clin Pract Oncol; 2008 Nov; 5(11):668-76. PubMed ID: 18825143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
    Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
    Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive radiotherapy for prostate cancer.
    Mendenhall WM; Henderson RH; Mendenhall NP
    Am J Clin Oncol; 2008 Oct; 31(5):496-503. PubMed ID: 18838889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node irradiation for prostate cancer: who, why, and when?
    Wang D; Lawton C
    Semin Radiat Oncol; 2008 Jan; 18(1):35-40. PubMed ID: 18082586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related quality of life in patients treated with multimodal therapy for prostate cancer.
    Wu AK; Cooperberg MR; Sadetsky N; Carroll PR
    J Urol; 2008 Dec; 180(6):2415-22; discussion 2422. PubMed ID: 18930279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of localized prostate cancer].
    Vallancien G; Cathelineau X; Rozet F; Barret E
    Bull Acad Natl Med; 2008 May; 192(5):1021-6; discussion 1026. PubMed ID: 19238791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinic.
    Taussky D; Liu A; Abrahamowicz M; Léger-Bélanger E; Bahary JP; Beauchemin MC; Nguyen TV; Donath D; Saad F
    Can J Urol; 2008 Dec; 15(6):4415-20. PubMed ID: 19046495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.